Trials / Terminated
TerminatedNCT03953261
Effect of Curcumin on Systemic Lupus Erythematosus
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigator initiated study is to determine the efficacy of curcumin on disease activity of subjects with systemic lupus erythematous. Curcumin has been found to have anti-inflammatory effects and has been found to improve disease activity in lupus patients. In addition, subjects with rheumatoid arthritis as well as osteoarthritis have also found benefit for their disease activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Curcumin supplement | Intervention is 2 grams of curcumin supplement per day |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2022-04-13
- Completion
- 2022-04-13
- First posted
- 2019-05-16
- Last updated
- 2022-08-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03953261. Inclusion in this directory is not an endorsement.